Trial Profile
A phase II clinical study of 5-FU and sorafenib combination therapy in patients with hepatocellular carcinoma. Uncontrolled exploratory clinical study
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 May 2016
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary) ; Fluorouracil
- Indications Liver cancer
- Focus Therapeutic Use
- 01 Nov 2012 New trial record